These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 1508841

  • 1. Comparative study of cisplatin and carboplatin on pharmacokinetics, nephrotoxicity and effect on renal nuclear DNA synthesis in rats.
    Yasumasu T, Ueda T, Uozumi J, Mihara Y, Kumazawa J.
    Pharmacol Toxicol; 1992 Feb; 70(2):143-7. PubMed ID: 1508841
    [Abstract] [Full Text] [Related]

  • 2. Ultrastructural alterations and DNA synthesis of renal cell nuclei following cisplatin or carboplatin injection in rats.
    Yasumasu T, Ueda T, Uozumi J, Mihara Y, Koikawa Y, Kumazawa J.
    J Pharm Pharmacol; 1992 Nov; 44(11):885-7. PubMed ID: 1361530
    [Abstract] [Full Text] [Related]

  • 3. Comparative nephrotoxicity of a novel platinum compound, cisplatin, and carboplatin in male Wistar rats.
    Wolfgang GH, Dominick MA, Walsh KM, Hoeschele JD, Pegg DG.
    Fundam Appl Toxicol; 1994 Jan; 22(1):73-9. PubMed ID: 8125216
    [Abstract] [Full Text] [Related]

  • 4. Experimental studies on the pharmacokinetics and nephrotoxicity of carboplatin (cis-diammine-1, 1-cyclobutane dicarboxylate platinum II) in rats.
    Ueda T, Yasumasu T, Uozumi J.
    J Toxicol Sci; 1991 Aug; 16(3):101-9. PubMed ID: 1942134
    [Abstract] [Full Text] [Related]

  • 5. Use of a toxicity factor to explain differences in nephrotoxicity and myelosuppression among the platinum antitumour derivatives cisplatin, carboplatin and nedaplatin in rats.
    Hanada K, Asano K, Nishimura T, Chimata T, Matsuo Y, Tsuchiya M, Ogata H.
    J Pharm Pharmacol; 2008 Mar; 60(3):317-22. PubMed ID: 18284811
    [Abstract] [Full Text] [Related]

  • 6. Tissue injury and repair in the rat kidney after exposure to cisplatin or carboplatin.
    Nonclercq D, Toubeau G, Laurent G, Tulkens PM, Heuson-Stiennon JA.
    Exp Mol Pathol; 1989 Oct; 51(2):123-40. PubMed ID: 2680578
    [Abstract] [Full Text] [Related]

  • 7. Comparative nephrotoxicity of carboplatin and cisplatin in euvolemic and dehydrated rats.
    Martinez F, Deray G, Dubois M, Beaufils H, Jacquiaud C, Bourbouze R, Benhmida M, Jaudon MC, Jacobs C.
    Anticancer Drugs; 1993 Feb; 4(1):85-90. PubMed ID: 8457719
    [Abstract] [Full Text] [Related]

  • 8. The relative nephrotoxicity of cisplatin, cis-[Pt(NH3)2(guanosine)2]2+, and the hydrolysis product of cisplatin in the rat.
    Jones MM, Basinger MA, Beaty JA, Holscher MA.
    Cancer Chemother Pharmacol; 1991 Feb; 29(1):29-32. PubMed ID: 1742846
    [Abstract] [Full Text] [Related]

  • 9. Differential toxicity of cisplatin, carboplatin, and CI-973 correlates with cellular platinum levels in rat renal cortical slices.
    Leibbrandt ME, Wolfgang GH.
    Toxicol Appl Pharmacol; 1995 Jun; 132(2):245-52. PubMed ID: 7785052
    [Abstract] [Full Text] [Related]

  • 10. Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: a report from the late effects surveillance system.
    Stöhr W, Paulides M, Bielack S, Jürgens H, Koscielniak E, Rossi R, Langer T, Beck JD.
    Pediatr Blood Cancer; 2007 Feb; 48(2):140-7. PubMed ID: 16724313
    [Abstract] [Full Text] [Related]

  • 11. Time response of carboplatin-induced nephrotoxicity in rats.
    Husain K, Whitworth C, Rybak LP.
    Pharmacol Res; 2004 Sep; 50(3):291-300. PubMed ID: 15225673
    [Abstract] [Full Text] [Related]

  • 12. Association between increased atrial natriuretic peptide and reduced cisplatin nephrotoxicity in rats.
    Ormond PM, Basinger MA, Jones MM, Hande KR.
    J Pharmacol Exp Ther; 1992 Jul; 262(1):246-51. PubMed ID: 1385629
    [Abstract] [Full Text] [Related]

  • 13. Renal tissue injury and proliferative response after successive treatments with anticancer platinum derivatives and tobramycin.
    Nonclercq D, Toubeau G, Tulkens P, Heuson-Stiennon JA, Laurent G.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1990 Jul; 59(3):143-58. PubMed ID: 1980761
    [Abstract] [Full Text] [Related]

  • 14. High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity.
    Thomas JP, Lautermann J, Liedert B, Seiler F, Thomale J.
    Mol Pharmacol; 2006 Jul; 70(1):23-9. PubMed ID: 16569706
    [Abstract] [Full Text] [Related]

  • 15. The effect of sodium thiosulfate on subcellular localization of platinum in rat kidney after treatment with cisplatin.
    Uozumi J, Litterst CL.
    Cancer Lett; 1986 Sep; 32(3):279-83. PubMed ID: 3768854
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prophylactic effect of methylprednisolone against cisplatin-induced nephrotoxicity in rats.
    Koikawa Y, Uozumi J, Ueda T, Yasumasu T, Kumazawa J.
    Toxicol Lett; 1993 Mar; 66(3):281-5. PubMed ID: 8475508
    [Abstract] [Full Text] [Related]

  • 18. Comparative nephrotoxicity of tetraplatin and cisplatin in rats.
    Rahman A, Roh JK, Preuss HG.
    Nephron; 1993 Mar; 64(2):289-95. PubMed ID: 8321364
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effects of platinum levels in plasma, urine, and kidney on blood urea nitrogen levels after cisplatin injection in rats.
    Uozumi J, Litterst CL.
    J Pharmacobiodyn; 1988 Apr; 11(4):277-83. PubMed ID: 3411443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.